<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34853443</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5462</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>3-4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Gene therapy</Title><ISOAbbreviation>Gene Ther</ISOAbbreviation></Journal><ArticleTitle>Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons.</ArticleTitle><Pagination><StartPage>178</StartPage><EndPage>192</EndPage><MedlinePgn>178-192</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41434-021-00303-4</ELocationID><Abstract><AbstractText>There are no effective cures for upper motor neuron (UMN) diseases, such as amyotrophic lateral sclerosis (ALS), primary lateral sclerosis, and hereditary spastic paraplegia. Here, we show UMN loss occurs independent of spinal motor neuron degeneration and that UMNs are indeed effective cellular targets for gene therapy, which offers a potential solution especially for UMN disease patients. UCHL1 (ubiquitin C-terminal hydrolase-L1) is a deubiquitinating enzyme crucial for maintaining free ubiquitin levels. Corticospinal motor neurons (CSMN, a.k.a UMNs in mice) show early, selective, and profound degeneration in Uchl1<sup>nm3419</sup> (UCHL1<sup>-/-</sup>) mice, which lack all UCHL1 function. When UCHL1 activity is ablated only from spinal motor neurons, CSMN remained intact. However, restoring UCHL1 specifically in CSMN of UCHL1<sup>-/-</sup> mice via directed gene delivery was sufficient to improve CSMN integrity to the healthy control levels. In addition, when UCHL1 gene was delivered selectively to CSMN that are diseased due to misfolded SOD1 toxicity and TDP-43 pathology via AAV-mediated retrograde transduction, the disease causing misfolded SOD1 and mutant human TDP-43 were reduced in hSOD1<sup>G93A</sup> and prpTDP-43<sup>A315T</sup> models, respectively. Diseased CSMN retained their neuronal integrity and cytoarchitectural stability in two different mouse models that represent two distinct causes of neurodegeneration in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gen&#xe7;</LastName><ForeName>Bar&#x131;&#x15f;</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jara</LastName><ForeName>Javier H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Santana S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagrimas</LastName><ForeName>Amiko K B</ForeName><Initials>AKB</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;z&#xfc;tok</LastName><ForeName>&#xd6;ge</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko&#xe7;ak</LastName><ForeName>Nuran</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yongling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Departments of Ophthalmology and Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hande &#xd6;zdinler</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-4125-6013</Identifier><AffiliationInfo><Affiliation>Davee Department of Neurology and Clinical Neurological Sciences, Northwestern University, Feinberg School of Medicine, Chicago, IL, 60611, USA. ozdinler@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS085161</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS085750</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Gene Ther</MedlineTA><NlmUniqueID>9421525</NlmUniqueID><ISSNLinking>0969-7128</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C482860">UCHL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C496976">Uchl1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest. Authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34853443</ArticleId><ArticleId IdType="mid">NIHMS1751670</ArticleId><ArticleId IdType="pmc">PMC9018479</ArticleId><ArticleId IdType="doi">10.1038/s41434-021-00303-4</ArticleId><ArticleId IdType="pii">10.1038/s41434-021-00303-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geevasinga N, Menon P, Ozdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nature reviews Neurology. 2016;12(11):651&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Klessner JL, Ozdinler PH. Retrograde labeling, transduction, and genetic targeting allow cellular analysis of corticospinal motor neurons: implications in health and disease. Front Neuroanat. 2014;8:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3972458</ArticleId><ArticleId IdType="pubmed">24723858</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon RN. Descending pathways in motor control. Annual review of neuroscience. 2008;31:195&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pubmed">18558853</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet A, Stuart-Lopez G, Burg T, Scekic-Zahirovic J, Rouaux C. Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis. Frontiers in neuroscience. 2020;14:363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201269</ArticleId><ArticleId IdType="pubmed">32410944</ArticleId></ArticleIdList></Reference><Reference><Citation>McColgan P, Joubert J, Tabrizi SJ, Rees G. The human motor cortex microcircuit: insights for neurodegenerative disease. Nature reviews Neuroscience. 2020;21(8):401&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32555340</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes ZI, Kan VWY, Ye X, Liebscher S. Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology. Frontiers in neuroscience. 2020;14(573):573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink JK. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta neuropathologica. 2013;126(3):307&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4045499</ArticleId><ArticleId IdType="pubmed">23897027</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink JK. Progressive spastic paraparesis: hereditary spastic paraplegia and its relation to primary and amyotrophic lateral sclerosis. Semin Neurol. 2001;21(2):199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">11442328</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Jara JH, Lagrimas AK, Pytel P, Roos RP, Mesulam MM, et al. Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep. 2017;7:41765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>Udaka F, Kameyama M, Tomonaga M. Degeneration of Betz cells in motor neuron disease. A Golgi study. Acta neuropathologica. 1986;70(3&#x2013;4):289&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">2429495</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH Jr., Robberecht W Amyotrophic lateral sclerosis: pathogenesis. Semin Neurol 2001;21(2):131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11442322</ArticleId></ArticleIdList></Reference><Reference><Citation>Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD, et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science. 2014;343(6170):506&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4157572</ArticleId><ArticleId IdType="pubmed">24482476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemon RN. The Cortical &#x201c;Upper Motoneuron&#x201d; in Health and Disease. Brain Sci. 2021;11(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8151778</ArticleId><ArticleId IdType="pubmed">34066053</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SM, Norris FH. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle &amp; nerve. 1993;16(8):864&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8332139</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43(3):470&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental neurology. 2004;185(2):232&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A The Dying Forward Hypothesis of ALS: Tracing Its History. Brain Sci. 2021;11(3).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997258</ArticleId><ArticleId IdType="pubmed">33673524</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle &amp; nerve. 1992;15(2):219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker MR. ALS--dying forward, backward or outward? Nature reviews Neurology. 2014;10(11):660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4221249</ArticleId><ArticleId IdType="pubmed">25245152</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrkiewicz M, Hausmanowa-Petrusewicz I. Amyotrophic lateral sclerosis: a dying motor unit? Frontiers in aging neuroscience. 2013;5:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607785</ArticleId><ArticleId IdType="pubmed">23533375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Brown RH, Jr. Amyotrophic Lateral Sclerosis: Fuel for the Corticofugal Feud. Annals of neurology. 2020;88(4):682&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32741003</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle &amp; nerve. 2001;24(4):564&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">11268031</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Cheah BC, Kiernan MC. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis. Experimental neurology. 2009;220(1):177&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">19716820</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Cheah BC, Yiannikas C, Kiernan MC. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol. 2011;122(9):1860&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21382747</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, et al.. Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS. Neurology. 2019;92(6):e536&#x2013;e47.</Citation><ArticleIdList><ArticleId IdType="pubmed">30709964</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomis D, Gooch C. Upper motor neuron assessment and early diagnosis in ALS: Getting it right the first time. Neurology. 2019;92(6):255&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30635480</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain : a journal of neurology. 2008;131(Pt 6):1540&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, et al. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2014;34(47):15587&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298650</ArticleId><ArticleId IdType="pubmed">25411487</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, et al. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis. Stem Cells. 2018;36(7):1122&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">29656478</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, Fischer M, Stuart-Lopez G, Burg T, Gilet J, Dirrig-Grosch S, et al. Evidence that corticofugal propagation of ALS pathology is not mediated by prion-like mechanism. Progress in neurobiology. 2021;200:101972.</Citation><ArticleIdList><ArticleId IdType="pubmed">33309802</ArticleId></ArticleIdList></Reference><Reference><Citation>Burg T, Bichara C, Scekic-Zahirovic J, Fischer M, Stuart-Lopez G, Brunet A, et al. Absence of Subcerebral Projection Neurons Is Beneficial in a Mouse Model of Amyotrophic Lateral Sclerosis. Annals of neurology. 2020;88(4):688&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540428</ArticleId><ArticleId IdType="pubmed">32588450</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. Journal of neurology, neurosurgery, and psychiatry. 2013;84(10):1161&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786661</ArticleId><ArticleId IdType="pubmed">23264687</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Geevasinga N, Yiannikas C, Howells J, Kiernan MC, Vucic S. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet neurology. 2015;14(5):478&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25843898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, McDermott CJ, Hardiman O, Shefner JM, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nature reviews Neurology. 2021;17(2):104&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Sue CM, Kumar KR, Ng K, Yiannikas C, et al. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol. 2015;22(5):826&#x2013;31, e57&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25683471</ArticleId></ArticleIdList></Reference><Reference><Citation>Day IN, Thompson RJ. UCHL1 (PGP 9.5): neuronal biomarker and ubiquitin system protein. Progress in neurobiology. 2010;90(3):327&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">19879917</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop P, Rocca D, Henley JM. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J. 2016;473(16):2453&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980807</ArticleId><ArticleId IdType="pubmed">27515257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT, Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson&#x2019;s disease susceptibility. Cell. 2002;111(2):209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">12408865</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, et al. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(9):3489&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587195</ArticleId><ArticleId IdType="pubmed">23359680</ArticleId></ArticleIdList></Reference><Reference><Citation>Das Bhowmik A, Patil SJ, Deshpande DV, Bhat V, Dalal A. Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79. J Hum Genet. 2018;63(8):927&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29735986</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydning SL, Backe PH, Sousa MML, Iqbal Z, Oye AM, Sheng Y, et al. Novel UCHL1 mutations reveal new insights into ubiquitin processing. Human molecular genetics. 2017;26(6):1217&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">28334853</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackstone C Converging cellular themes for the hereditary spastic paraplegias. Current opinion in neurobiology. 2018;51:139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6066444</ArticleId><ArticleId IdType="pubmed">29753924</ArticleId></ArticleIdList></Reference><Reference><Citation>McMacken G, Lochmuller H, Bansagi B, Pyle A, Lochmuller A, Chinnery PF, et al. Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion. Journal of neurology. 2020;267(12):3643&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674332</ArticleId><ArticleId IdType="pubmed">32656641</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters BJ, Campbell SL, Chen PC, Taylor AP, Schroeder DG, Dobrunz LE, et al. Differential effects of Usp14 and Uch-L1 on the ubiquitin proteasome system and synaptic activity. Molecular and cellular neurosciences. 2008;39(4):539&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2734958</ArticleId><ArticleId IdType="pubmed">18771733</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Cox GA, Bohn MC, Roos RP, Macklis JD, et al. Corticospinal Motor Neurons Are Susceptible to Increased ER Stress and Display Profound Degeneration in the Absence of UCHL1 Function. Cereb Cortex. 2015;25(11):4259&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626833</ArticleId><ArticleId IdType="pubmed">25596590</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Jara JH, Schultz MC, Manuel M, Stanford MJ, Gautam M, et al. Absence of UCHL 1 function leads to selective motor neuropathy. Ann Clin Transl Neurol. 2016;3(5):331&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4863746</ArticleId><ArticleId IdType="pubmed">27231703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH Jr., Macklis JD. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(9)(3)A transgenic ALS mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2011;31(11):4166&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasvoina MV, Genc B, Jara JH, Sheets PL, Quinlan KA, Milosevic A, et al. eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2013;33(18):7890&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3963467</ArticleId><ArticleId IdType="pubmed">23637180</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Gozutok O, Kocak N, Ozdinler PH. The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord. Cells. 2020;9(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072754</ArticleId><ArticleId IdType="pubmed">32098365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264(5166):1772&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Kocak N, Rylaarsdam LE, Kim KD, Bigio EH, et al. Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta neuropathologica. 2019;137(1):47&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(44):18809&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Ozdinler PH. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Human molecular genetics. 2016;25(6):1074&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4764190</ArticleId><ArticleId IdType="pubmed">26755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Fil D, DeLoach A, Yadav S, Alkam D, MacNicol M, Singh A, et al. Mutant Profilin1 transgenic mice recapitulate cardinal features of motor neuron disease. Human molecular genetics. 2017;26(4):686&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968635</ArticleId><ArticleId IdType="pubmed">28040732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Annals of neurology. 2007;61(5):427&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Sanelli T, Xiao S, Yang W, Horne P, Hammond R, et al. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neuroscience letters. 2007;420(2):128&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17543992</ArticleId></ArticleIdList></Reference><Reference><Citation>Maekawa S, Leigh PN, King A, Jones E, Steele JC, Bodi I, et al. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology. 2009;29(6):672&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19496940</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Archives of neurology. 2007;64(10):1388&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">17923623</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Gautam M, Gozutok O, Dervishi I, Sanchez S, Goshu GM, et al. Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP-43 pathology. Clin Transl Med. 2021;11(2):e336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898037</ArticleId><ArticleId IdType="pubmed">33634973</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerfen CR, Paletzki R, Heintz N. GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits. Neuron. 2013;80(6):1368&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3872013</ArticleId><ArticleId IdType="pubmed">24360541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Hughes EG, Shetty AS, Arlotta P, Goff LA, Bergles DE, et al. Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2017;37(37):9037&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone DP, Heavner WE, Ferenczi EA, Dobreva G, Huguenard JR, Grosschedl R, et al. Satb2 Regulates the Differentiation of Both Callosal and Subcerebral Projection Neurons in the Developing Cerebral Cortex. Cereb Cortex. 2015;25(10):3406&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4585495</ArticleId><ArticleId IdType="pubmed">25037921</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodworth MB, Greig LC, Liu KX, Ippolito GC, Tucker HO, Macklis JD. Ctip1 Regulates the Balance between Specification of Distinct Projection Neuron Subtypes in Deep Cortical Layers. Cell Rep. 2016;15(5):999&#x2013;1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873759</ArticleId><ArticleId IdType="pubmed">27117402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, Heintz N, et al. Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2007;27(37):9817&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6672645</ArticleId><ArticleId IdType="pubmed">17855595</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003;425(6961):917&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">14586460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Arber S, William C, Li L, Tanabe Y, Jessell TM, et al. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation. Neuron. 2001;30(2):399&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">11395002</ArticleId></ArticleIdList></Reference><Reference><Citation>Arber S, Han B, Mendelsohn M, Smith M, Jessell TM, Sockanathan S. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron. 1999;23(4):659&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">10482234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lock M, Alvira M, Vandenberghe LH, Samanta A, Toelen J, Debyser Z, et al. Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale. Hum Gene Ther. 2010;21(10):1259&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957274</ArticleId><ArticleId IdType="pubmed">20497038</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Y, Xu J, Hauswirth WW, DeVries SH. Genetically targeted binary labeling of retinal neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2014;34(23):7845&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4044247</ArticleId><ArticleId IdType="pubmed">24899708</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Villa SR, Khan NA, Bohn MC, Ozdinler PH. AAV2 mediated retrograde transduction of corticospinal motor neurons reveals initial and selective apical dendrite degeneration in ALS. Neurobiology of disease. 2012;47(2):174&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049520</ArticleId><ArticleId IdType="pubmed">22521461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, Soucy G, Lariviere R, Julien JP. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. Journal of neurochemistry. 2010;113(5):1188&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">20345765</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002;110(3):385&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">12176325</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JM, Hartley R, Maxwell DJ, Todd AJ, Lieberam I, Kaltschmidt JA, et al. Conditional rhythmicity of ventral spinal interneurons defined by expression of the Hb9 homeodomain protein. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2005;25(24):5710&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6724883</ArticleId><ArticleId IdType="pubmed">15958737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer ER, Knott L, Su F, Dessaud E, Krull CE, Helmbacher F, et al. Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb. Neuron. 2006;50(1):35&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16600854</ArticleId></ArticleIdList></Reference><Reference><Citation>Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, Didonato CJ. Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2012;32(11):3818&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3679185</ArticleId><ArticleId IdType="pubmed">22423102</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD. Neuronal subtype specification in the cerebral cortex. Nature reviews Neuroscience. 2007;8(6):427&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">17514196</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneaux BJ, Arlotta P, Macklis JD. Molecular development of corticospinal motor neuron circuitry. Novartis Foundation symposium. 2007;288(2):3&#x2013;15; discussion &#x2212;20, 96&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18494249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ. Driven to decay: Excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain research bulletin. 2018;140:318&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29870780</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ. Amyotrophic lateral sclerosis as a synaptopathy. Neural Regen Res. 2019;14(2):189&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6301167</ArticleId><ArticleId IdType="pubmed">30530995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Klenowski PM, Lee JD, Drieberg-Thompson JR, Bartlett SE, Ngo ST, et al. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep. 2016;6:37968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5126629</ArticleId><ArticleId IdType="pubmed">27897242</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Mu EW, Noakes PG, Lavidis NA, Bellingham MC. Marked changes in dendritic structure and spine density precede significant neuronal death in vulnerable cortical pyramidal neuron populations in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2016;4(1):77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973034</ArticleId><ArticleId IdType="pubmed">27488828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Noakes PG, Bellingham MC. Motor cortex layer V pyramidal neurons exhibit dendritic regression, spine loss, and increased synaptic excitation in the presymptomatic hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2015;35(2):643&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605367</ArticleId><ArticleId IdType="pubmed">25589758</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley EE, Pitman KA, Dawkins E, Young KM, Clark RM, Jiang TC, et al. Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies. Cereb Cortex. 2017;27(7):3630&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">27496536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, et al. Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis. Journal of neuropathology and experimental neurology. 2017;76(5):402&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901081</ArticleId><ArticleId IdType="pubmed">28521037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Xie EF, Kocak N, Ozdinler PH. Mitoautophagy: A Unique Self-Destructive Path Mitochondria of Upper Motor Neurons With TDP-43 Pathology Take, Very Early in ALS. Front Cell Neurosci. 2019;13:489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6854036</ArticleId><ArticleId IdType="pubmed">31787882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362(6415):59&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Sanelli T, Xiao SX, Yang WC, Horne P, Hammond R, et al. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS. Neuroscience letters. 2007;420(2):128&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">17543992</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinicke AT, Laban K, Sachs M, Kraus V, Walden M, Damme M, et al. Ubiquitin C-terminal hydrolase L1 (UCH-L1) loss causes neurodegeneration by altering protein turnover in the first postnatal weeks. Proceedings of the National Academy of Sciences of the United States of America. 2019;116(16):7963&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475369</ArticleId><ArticleId IdType="pubmed">30923110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachiller S, Alonso-Bellido IM, Real LM, Perez-Villegas EM, Venero JL, Deierborg T, et al. The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement. Int J Mol Sci. 2020;21(17).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7503226</ArticleId><ArticleId IdType="pubmed">32899400</ArticleId></ArticleIdList></Reference><Reference><Citation>Coan G, Mitchell CS. An Assessment of Possible Neuropathology and Clinical Relationships in 46 Sporadic Amyotrophic Lateral Sclerosis Patient Autopsies. Neuro-degenerative diseases. 2015;15(5):301&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4560965</ArticleId><ArticleId IdType="pubmed">26183171</ArticleId></ArticleIdList></Reference><Reference><Citation>Dervishi I, Gozutok O, Murnan K, Gautam M, Heller D, Bigio E, et al. Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS. Sci Rep. 2018;8(1):14732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170493</ArticleId><ArticleId IdType="pubmed">30283000</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2018;17(9):660&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456907</ArticleId><ArticleId IdType="pubmed">30116051</ArticleId></ArticleIdList></Reference><Reference><Citation>Turker F, Cook EK, Margolis SS. The proteasome and its role in the nervous system. Cell Chem Biol. 2021;28(7):903&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8286317</ArticleId><ArticleId IdType="pubmed">33905676</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicardi ME, Marrone L, Azzouz M, Trotti D. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. EMBO J. 2021;40(10):e106389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8126909</ArticleId><ArticleId IdType="pubmed">33792056</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham SH, Liu H. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia. Ageing Res Rev. 2017;34:30&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5250550</ArticleId><ArticleId IdType="pubmed">27702698</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Frank DD, Ozdinler PH. Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1. Cell biochemistry and biophysics. 2013;67(1):45&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23695785</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CT, Sheets PL, Kiritani T, Shepherd GM. Sublayer-specific microcircuits of corticospinal and corticostriatal neurons in motor cortex. Nature neuroscience. 2010;13(6):739&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876193</ArticleId><ArticleId IdType="pubmed">20436481</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd GM. Corticostriatal connectivity and its role in disease. Nature reviews Neuroscience. 2013;14(4):278&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096337</ArticleId><ArticleId IdType="pubmed">23511908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Stanford MJ, Pytel P, Roos RP, Weintraub S, et al. Evidence for an early innate immune response in the motor cortex of ALS. J Neuroinflammation. 2017;14(1):129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Rose ME, Ma X, Culver S, Dixon CE, Graham SH. In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury. PloS one. 2017;12(5):e0178049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443532</ArticleId><ArticleId IdType="pubmed">28542502</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Li W, Ahmad M, Miller TM, Rose ME, Poloyac SM, et al. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiology of disease. 2011;41(2):318&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014436</ArticleId><ArticleId IdType="pubmed">20933087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell. 2006;126(4):775&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">16923396</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon WW, Carlos AJ, Aguilar BL, Berchtold NC, Kawano CK, Zograbyan V, et al. beta-Amyloid (Abeta) oligomers impair brain-derived neurotrophic factor retrograde trafficking by down-regulating ubiquitin C-terminal hydrolase, UCH-L1. The Journal of biological chemistry. 2013;288(23):16937&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675626</ArticleId><ArticleId IdType="pubmed">23599427</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>